ALNOZINE™ Dietary Supplement
Alnozine™ is designed to support a generally healthy lifestyle and well-being. This unique pharmabiotic product is derived from yeast cells treated with electromagnetic millimeter waves, which may contribute to the body's general function, an important part of a healthy lifestyle.
IBS - A Daily Challenge
Irritable Bowel Syndrome (IBS) is one of the most widespread and costly gastrointestinal disorders. Globally, the prevalence of IBS is estimated to be around 15%, with symptoms occurring in about 10-20% of the population in Western countries. The condition is characterized by symptoms such as abdominal pain, bloating, and irregular bowel movement. These symptoms can lead to a significant deterioration in the quality of life for affected individuals.
Alnozine, developed by Milmed Unico AB, is classified as a dietary supplement and adheres to the regulations set by the National Food Agency. This unique pharmabiotic product is derived from yeast cells treated with electromagnetic millimeter waves. It is designed to be part of a balanced diet and contribute to a less troubled stomach.
Alnozine (Milmed) är patentskyddat, patentnr PCT/SE2022/050656 ”YEAST FOR THE TREATMENT OF INFLAMMATION”. Grund för patentet är två studier studier som bägge är publicerade vetenskapliga artiklar, se OM ALNOZINE.
Allergies - A Growing Global Health Issue
Allergies are hypersensitivity reactions of the immune system to various substances in the environment, known as allergens. Symptoms can range from mild to life-threatening and include sneezing, runny nose, itching, rashes, and asthma. With a steady increase in allergic diseases globally, society faces a growing need for effective treatments.
Alnozine™, developed by Milmed Unico AB, is an innovative dietary supplement. This unique pharmabiotic product is derived from yeast cells treated with electromagnetic millimeter waves. It is designed to be part of a balanced diet and contribute to a less stressful and more harmonious everyday life.
Alnozine (Milmed) är patentskyddat, patentnr PCT/SE2020/050958 ”YEAST FOR THE TREATMENT OF ALLERGY”. Grund för patentet är flera olika studier som alla är publicerade vetenskapliga artiklar, se OM ALNOZINE.
